Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05654454
What this trial is testing

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Mabscale, LLC 620
Not applicableUnknownNCT00192829
What this trial is testing

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Who this might be right for
Non-Small Cell Lung CarcinomaVenous Thromboembolism
Rambam Health Care Campus 100
Large-scale testing (Phase 3)Study completedNCT01282437
What this trial is testing

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Radical TreatmentStage III Non-Small Cell Lung Cancer
Maastricht Radiation Oncology 315
Testing effectiveness (Phase 2)Study completedNCT00103831
What this trial is testing

Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Bristol-Myers Squibb
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Testing effectiveness (Phase 2)Study completedNCT03472053
What this trial is testing

BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage IIIB
BioMarck Pharmaceuticals, Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Early research (Phase 1)Study completedNCT02145637
What this trial is testing

Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC
Yonsei University 30
Testing effectiveness (Phase 2)Study completedNCT00238875
What this trial is testing

A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)

Who this might be right for
T1N0M0 Non-small Cell Lung Cancer
Haruhiko Fukuda 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT02422381
What this trial is testing

MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Providence Health & Services 16
Testing effectiveness (Phase 2)UnknownNCT00809237
What this trial is testing

Hydroxychloroquine and Gefitinib to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
National University Hospital, Singapore 71
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Early research (Phase 1)Ended earlyNCT05571839
What this trial is testing

PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerColorectal Neoplasms+2 more
Seagen, a wholly owned subsidiary of Pfizer 41
Testing effectiveness (Phase 2)Looking for participantsNCT07012031
What this trial is testing

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01221077
What this trial is testing

Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene

Who this might be right for
NSCLCNon Small Cell Lung Cancer
Astellas Pharma Inc 88
Not applicableUnknownNCT02803619
What this trial is testing

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal Metastasis
Peking Union Medical College Hospital 60
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Ended earlyNCT05849246
What this trial is testing

The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 4
Testing effectiveness (Phase 2)WithdrawnNCT01179269
What this trial is testing

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Loyola University
Next Page